ToxIndex

Sample Report

Propylparaben: What 1,153 Data Sources Reveal About Safety

A complete toxicological risk assessment of propylparaben (CAS 94-13-3) — covering 26 endpoints from substance identification through hazard classification — generated by ToxIndex from hundreds of regulatory, scientific, and computational sources.

CAS 94-13-3 26 Sections 1,153 Cited Claims

Key Findings

The assessment integrates data from EU SCCS, ECHA, Health Canada, FDA, ToxCast/Tox21 in vitro screening, peer-reviewed literature, and QSAR predictions. Here's a preview of what the report covers.

Carcinogenicity

Mouse studies at FDA-acceptable doses found significant mammary tumor growth and metastasis. The report walks through 5 computational models and the full weight-of-evidence assessment.

Endocrine Disruption

Multiple lines of evidence point to estrogen receptor activation and antiandrogenic activity. The report maps out the full adverse outcome pathway with cited evidence at every step.

Reproductive Toxicity

Findings span prenatal exposure effects in humans to multigenerational animal studies. The report synthesizes data from epidemiological and experimental sources across 3 related sections.

Regulatory Gaps

Health Canada and the EU SCCS have both flagged propylparaben, but key OECD guideline studies are still missing. The report identifies exactly which data gaps remain.

What's in the report

The full assessment covers 26 sections with cited evidence for every claim. Each finding links back to its source — regulatory databases, peer-reviewed studies, or computational predictions — so you can verify everything.

1 Substance Identification
2 Metabolites & Biotransformation
3 Chemical Transformation
4 Toxicokinetics (ADME)
5 Environmental Fate
6 Acute Toxicity
7 Repeat-Dose Toxicity
8 Genotoxicity
9 Carcinogenicity
10 Reproductive Toxicity
11 Developmental Toxicity
12 Neurotoxicity
13 Hepatotoxicity
14 Hematotoxicity
15 Immunotoxicity
16 Dermal & Ocular Toxicity
17 Endocrine Disruption
18 Ecotoxicity
19 Dose-Response Assessment
20 Species Differences
21 Read-Across Analysis
22 Risk Characterization
23 Hazard Classifications
24 OECD/REACH Readiness
25 Data Gaps & Testing Strategy
26 Executive Summary
Read the Full Report

How this report was built

This assessment was generated by ToxIndex in hours — not the weeks a manual literature review would require. An agentic pipeline orchestrated every step, from data retrieval through hazard classification, with a full audit trail.

Curated Datasets

Hundreds of linked chemistry and toxicology datasets from PubChem, DSSTox, CompTox, ECHA, FDA, WHO, and more — all cross-referenced into a single knowledge graph.

Predictive Models

Hundreds of computational toxicology models including QSAR Toolbox, ToxTransformer, OPERA, VEGA, and LD50 predictions — run automatically for every endpoint.

Regulatory Search

Millions of documents from 50+ regulatory agencies searched, classified, and cited. Every claim in the report links back to its source.

Want this for your compound?

Send us a CAS number and we'll generate a preview within 24 hours.